Drug news
EC 906 filed by Astellas foe EU approval for LUTS associated with BPH
Astellas Pharma Europe has filed EC 905 its fixed dose combination of Flomaxtra XL (tamsulosin) and Vesicare(solifenacin)in the Netherlands under the EU Mutual Recognition Scheme for lower urinary tract symptoms associated with Benign Prostatic Hyperplasia.